Astronova, Inc. · NASDAQ:ALOT
Astronova — Q4 2026 Earnings Presentation
16 slides from Astronova's earnings presentation, Apr 14, 2026
Slide 1: Fourth Quarter FY2026 Financial Results
Fourth Quarter FY2026 Jorik Ittmann, President and CEO Tom DeByle, Chief Financial Officer Financial Results Printing Technologies for Critical Applications April 13, 2026 AstroNova Nasdaq: ALOT
Slide 2: Cautionary Statement; Use of Non-GAAP Financial Measures
Cautionary Statement Use of Non-GAAP Financial Measures Information included in this presentation may contain forward-looking statements In addition to financial measures prepared in accordance with generally accepted within the meaning of the Private Securities Litigation Reform Act of 1995. accoun
Slide 3: Fiscal 2026: A Foundational Reset Year
Fiscal 2026: A Foundational Reset Year Product ID Turnaround Gaining Momentum Aerospace Delivered Strong Full-Year Performance Reduced Debt and Strengthened Balance Sheet Evaluating Strategic Alternatives to Unlock Value AstroNova 3
Slide 4: Revenue
Revenue ($ in millions) QUARTERS 1H and 2H FY 2026 $73.8 $76.7 Product ID 2HFY26 sales up 4.2% vs. 1HFY26 $37.4 $37.5 $22.8 $23.5 • Q4 FY26 sales up 2.5% Y/Y $11.7 $11.2 • Aftermarket revenue remained strong, representing $51.0 $53.2 approximately 80% of segment sales $25.7 $26.3 • New go-to-market
Slide 5: Gross Profit and Margin
Gross Profit and Margin ($ in millions) Gross Profit and Margin QUARTERS 1H v. 2H FY2026 FULL YEAR $50.7 $47.6 $24.8 $22.9 $12.2 $11.3 Q4 gross profit margin contracted 256 bps 32.7% 30.2% 31.0% 32.3% 33.5% 31.6% Y/Y to 30.2% reflecting lower volume and mix Q4 2025 Q4 2026 1HFY26 2HFY26 FY2025 FY202
Slide 6: Operating Profit and Margin
Operating Profit and Margin ($ in millions) Operating Profit and Margin QUARTERS 1H v. 2H FY26 FULL YEAR $1.2 0.8% $0.1 $1.3 Q4 2025 Q4 2026 -$0.1 FY 2025 FY 2026 Adjusted operating margin expanded 220 bps -33.0% 0.1% -0.2% 1.7% -5.7% from first half to second half of FY2026 1HFY26 2HFY26 -$12.3 -$8
Slide 7: EPS and Adj. EBITDA
EPS and Adj. EBITDA ($ in millions, except per share data) Net Earnings (Loss) and Adjusted EBITDA/ EPS and Adjusted EPS1 Adjusted EBITDA Margin 1 $2.8 $3.3 $0.06 7.5% 8.8% $(0.04) ($1.1) $(0.15) ($15.6) $(2.07) Q4 FY25 Q4 FY26 Q4 FY25 Q4 FY26 $12.3 $12.7 $0.32 $0.16 8.2% 8.4% $(0.31) ($2.4) ($14.5)
Slide 8: Capital Structure and Cash Flow
Capital Structure and Cash Flow ($ in millions) Cash Flow Twelve Months Ended Capitalization 1/31/26 1/31/25 1/31/26 10/31/25 1/31/25 Net cash provided by operating Cash and cash $ 11.7 $ 4.8 $ 4.1 $ 3.6 $ 5.1 activities equivalents Total debt $ 37.6 $ 40.3 $ 46.7 Capital expenditure 0.3 1.2 Shareho
Slide 9: Orders and Backlog
Orders and Backlog ($ in millions) PRODUCT ID Orders $38.6 $41.1 $34.9 $35.9 $35.9 $13.6 $14.1 $8.7 Product ID Q4FY26 orders grew $2.9 million Y/Y as $12.5 $13.4 new go-to-market strategy gains traction; book-to-bill of 104% $24.5 $26.2 $23.4 $22.5 $27.5 Backlog increased by $1.1 million sequentiall
Slide 10: Plan for Growth
Plan for Growth Driving Change – Focused Resources in Sales & Marketing | Strengthening Operational Execution • Driving culture change: honesty, transparency, and accelerated and engaged decision making • Executive leadership deeply engaged with team and customers; leveraging commercial print indust
Slide 11: Conference Call Playback; Investor Relations Contact
Conference Call Playback Replay Number: Investor Relations Contact: (412) 317-6671 | passcode: 13759000 Deborah K. Pawlowski UPCOMING EVENTS Telephone replay available through Phone: 716.843.3908 Tuesday, April 28, 2026 Email: dpawlowski@allianceadvisors.com Webcast / Presentation / Webcast Replay:
Slide 12: Supplemental Information
Supplemental Information 12
Slide 13: Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit
ASTRONOVA Reconciliation of GAAP Gross Profit to Non-GAAP Gross Profit Three Months Ended Twelve Months Ended 2H Fiscal 2026 and 1H Fiscal 2026 January 31, January 31, January 31, January 31, 2026 2025 2026 2025 2H FY26 1H FY26 Revenue $ 37,536 $ 37,361 $ 150,515 $ 151,283 $ 76,705 $ 73,810 Gross Pr
Slide 14: Reconciliation of GAAP Operating Income to Non-GAAP Operating Income
ASTRONOVA Reconciliation of GAAP Operating Income to Non-GAAP Operating Income Three Months Ended Twelve Months Ended 2H Fiscal 2026 and 1H Fiscal 2026 January 31, January 31, January 31, January 31, 2026 2025 2026 2025 2H FY26 1H FY26 Revenue $ 37,536 $ 37,361 $ 150,515 $ 151,283 $ 76,705 $ 73,810
Slide 15: Reconciliation of Net Income to Adjusted EBITDA
ASTRONOVA Reconciliation of Net Income to Adjusted EBITDA Twelve Months Ended Three Months Ended January 31, January 31, January 31, January 31, 2026 2025 2026 2025 Net Income (Loss) $ (2,376) $ (14,489) Net Income (Loss) $ (1,134) $ (15,600) Interest Expense 3,503 3,210 Interest Expense 894 847 Inc
Slide 16: Reconciliation of Net Income to Adjusted Net Income
ASTRONOVA Reconciliation of Net Income to Adjusted Net Income Three Months Ended Twelve Months Ended January 31, January 31, January 31, January 31, 2026 2025 2026 2025 Revenue $ 37,536 $ 37,361 $ 150,515 $ 151,283 Net Income (Loss) $ (1,134) $ (15,600) $ (2,376) $ (14,489) MTEX-related Acquisition